Platform Specialty Products Stock Price, News & Analysis (NYSE:PAH)

Platform Specialty Products trades on the New York Stock Exchange (NYSE) under the ticker symbol "PAH."

Platform Specialty Products Corp (NYSE:PAH) issued its quarterly earnings results on Thursday, August, 2nd. The specialty chemicals company reported $0.26 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $0.24 by $0.02. The specialty chemicals company earned $1 billion during the quarter, compared to the consensus estimate of $997.27 million. Platform Specialty Products had a positive return on equity of 8.48% and a negative net margin of 14.14%. The company's revenue for the quarter was up 6.5% on a year-over-year basis. During the same period last year, the company earned $0.20 earnings per share. View Platform Specialty Products' Earnings History.

4 equities research analysts have issued twelve-month price objectives for Platform Specialty Products' stock. Their predictions range from $12.00 to $15.00. On average, they anticipate Platform Specialty Products' share price to reach $13.6667 in the next year. View Analyst Price Targets for Platform Specialty Products.

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Platform Specialty Products in the last year. There are currently 2 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Platform Specialty Products.

Press coverage about PAH stock has trended negative recently, according to InfoTrie Sentiment Analysis. InfoTrie identifies negative and positive news coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Platform Specialty Products earned a news impact score of -2.9 on InfoTrie's scale. They also gave media headlines about the specialty chemicals company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an impact on the stock's share price in the next several days. View News Stories for Platform Specialty Products.

Some companies that are related to Platform Specialty Products include Versum Materials (VSM), Element Solutions (ESI), Cabot (CBT), WD-40 (WDFC), Orion Engineered Carbons (OEC), Advanced Emissions Solutions (ADES), Flotek Industries (FTK), Pure Bioscience (PURE), HighCom Global Security (HCGS), GlyEco (GLYE), Artemis Therapeutics (ATMS) and Ener-Core (ENCR).

Based on aggregate information from My MarketBeat watchlists, some companies that other Platform Specialty Products investors own include Two Harbors Investment (TWO), Micron Technology (MU), Uniti Group (UNIT), Freeport-McMoRan (FCX), General Electric (GE), Eagle Bulk Shipping (EGLE), Alibaba Group (BABA), Chesapeake Energy (CHK), Kinder Morgan (KMI) and Kratos Defense & Security Solutions (KTOS).

Platform Specialty Products' stock is owned by a variety of of retail and institutional investors. Top institutional investors include Peregrine Capital Management LLC (0.66%), Wedge Capital Management L L P NC (0.45%), PenderFund Capital Management Ltd. (0.27%), Swiss National Bank (0.15%), Arlington Partners LLC (0.05%) and Tributary Capital Management LLC (0.05%). Company insiders that own Platform Specialty Products stock include Benjamin Gliklich, Diego Lopez Casanello, Ian G H Ashken, John David Tolbert, John Edward Capps, Martin E Franklin, Pershing Square Capital Manage and Scot Benson. View Institutional Ownership Trends for Platform Specialty Products.

PAH stock was sold by a variety of institutional investors in the last quarter, including PenderFund Capital Management Ltd., Wedge Capital Management L L P NC, WINTON GROUP Ltd, Tributary Capital Management LLC, Peregrine Capital Management LLC and Investors Research Corp. Company insiders that have sold Platform Specialty Products company stock in the last year include Martin E Franklin and Pershing Square Capital Manage. View Insider Buying and Selling for Platform Specialty Products.

PAH stock was acquired by a variety of institutional investors in the last quarter, including Arlington Partners LLC, Webster Bank N. A., Quantitative Systematic Strategies LLC, Stevens Capital Management LP and Swiss National Bank. Company insiders that have bought Platform Specialty Products stock in the last two years include Benjamin Gliklich, Diego Lopez Casanello, Ian G H Ashken, John David Tolbert, John Edward Capps, Martin E Franklin, Pershing Square Capital Manage and Scot Benson. View Insider Buying and Selling for Platform Specialty Products.

Shares of PAH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

Platform Specialty Products has a market capitalization of $0.00 and generates $3.78 billion in revenue each year. The specialty chemicals company earns $-296,200,000.00 in net income (profit) each year or $0.76 on an earnings per share basis. View Additional Information About Platform Specialty Products.

The official website for Platform Specialty Products is http://www.platformspecialtyproducts.com/.

Platform Specialty Products' mailing address is 1450 CENTREPARK BLVD SUITE 210, WEST PALM BEACH FL, 33401. The specialty chemicals company can be reached via phone at (561) 207-9600.